Bonus BioGroup Ltd. (TLV:BONS)
15.00
-0.70 (-4.46%)
Nov 19, 2026, 5:14 PM IST
Bonus BioGroup Market Cap
Bonus BioGroup has a market cap or net worth of 175.22 million as of November 19, 2026. It is the 28,939th most valuable company in the world and the 332nd biggest in Israel. Its market cap has decreased by 28.90% in one year.
Market Cap
175.22M
Enterprise Value
182.96M
Revenue
n/a
Global Rank
Country Rank
#332 Israel
PE Ratio
n/a
ChartMarket Cap Chart
Since July 25, 2012, Bonus BioGroup's market cap has increased from 12.36M to 175.22M, an increase of 1,317.34%. That is a compound annual growth rate of 20.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 175.22M | -40.23% |
| Dec 31, 2025 | 293.15M | 110.92% |
| Dec 31, 2024 | 138.98M | -28.74% |
| Dec 31, 2023 | 195.04M | -13.02% |
| Dec 29, 2022 | 224.24M | -84.58% |
| Dec 30, 2021 | 1.45B | 200.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Matricelf | 80.72M |
| Purple Biotech | 32.42M |
| Clal Biotechnology Industries | 32.15M |
| BioLineRx | 29.87M |
| BioLight Life Sciences | 27.24M |
| XTL Biopharmaceuticals | 18.54M |
| Evogene | 18.49M |
| Can-Fite BioPharma | 16.04M |